| pubmed-article:9722203 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C0021734 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C1623038 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:9722203 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:9722203 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9722203 | pubmed:dateCreated | 1998-10-30 | lld:pubmed |
| pubmed-article:9722203 | pubmed:abstractText | Our aim was to assess and compare the long-term effect of interferon at standard (6 months) and reinforced dose and duration regimens in chronic hepatitis C. | lld:pubmed |
| pubmed-article:9722203 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9722203 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9722203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9722203 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9722203 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9722203 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:DegosFF | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:ChastangCC | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:NaveauSS | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:ChevretSS | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:BaillyFF | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:MoussalliJJ | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:GaynoSS | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:Chaumet-Riffa... | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:DauratVV | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:RiachiGG | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:BastieAA | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:BarangeKK | lld:pubmed |
| pubmed-article:9722203 | pubmed:author | pubmed-author:Bartolomei-Po... | lld:pubmed |
| pubmed-article:9722203 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9722203 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:9722203 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9722203 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9722203 | pubmed:pagination | 224-32 | lld:pubmed |
| pubmed-article:9722203 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:meshHeading | pubmed-meshheading:9722203-... | lld:pubmed |
| pubmed-article:9722203 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9722203 | pubmed:articleTitle | Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group. | lld:pubmed |
| pubmed-article:9722203 | pubmed:affiliation | Service d'Hépatogastroentérologie, Hôpital Beaujon, Clichy, France. | lld:pubmed |
| pubmed-article:9722203 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9722203 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9722203 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9722203 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9722203 | pubmed:publicationType | Multicenter Study | lld:pubmed |
